Emily Kelty

Analyst, Quantitative Research and Strategy

Emily Kelty is an Analyst, with the Quantitative Research & Strategy team at RA Capital Management. Emily’s primary responsibility is to support the Investment Team by leveraging healthcare data to inform investments. Prior to RA Capital, Emily specialized in Commercial Analytics at Sarepta Therapeutics and Alexion Pharmaceuticals supporting executive launch reporting and synthesizing insights across the organization. Additionally, Emily held a Business Analytics Associate role at RA Capital, where she created novel analyses and tools. Emily holds a BS in Health Sciences from the University of Connecticut.